Literature DB >> 20051493

Firing probability and mean firing rates of human muscle vasoconstrictor neurones are elevated during chronic asphyxia.

Cynthia Ashley1, Danielle Burton, Yrsa B Sverrisdottir, Mikael Sander, David K McKenzie, Vaughan G Macefield.   

Abstract

Elevated muscle sympathetic nerve activity (MSNA) features in many cardiovascular diseases, but how this sympathoexcitation is brought about differs across pathologies. Unitary recordings from post-ganglionic muscle vasoconstrictor neurones in human subjects have shown that the augmented MSNA in the obstructive sleep apnoea syndrome (OSAS) is associated with an increase in firing probability and mean firing rate, and an increase in multiple within-burst firing. Here we characterize the firing properties of muscle vasoconstrictor neurones in patients with chronic obstructive pulmonary disease (COPD), who are chronically asphyxic. We tested the hypothesis that this elevated chemical drive would shift the firing pattern from that seen in healthy subjects to that seen in OSAS. The mean firing probability (52%) and mean firing rate (0.92 Hz) of 17 muscle vasoconstrictor neurones recorded in COPD were comparable to those previously recorded in OSAS (51% and 0.96 Hz), but significantly higher than those recorded in a group of healthy subjects with high levels of resting MSNA (35% and 0.33 Hz). In COPD single neurones fired once in 63% of cardiac intervals, comparable to OSAS (59%), but significantly lower than in the healthy group (78%). Conversely, single neurones fired twice in 25% of cardiac intervals, similar to OSAS (27%), but significantly higher than in the healthy group (18%). We conclude that the chronic asphyxia associated with COPD results in an increase in the firing probability and mean firing frequency of muscle vasoconstrictor neurones and causes a shift towards multiple firing, reflecting an increase in central muscle vasoconstrictor drive.

Entities:  

Mesh:

Year:  2010        PMID: 20051493      PMCID: PMC2828141          DOI: 10.1113/jphysiol.2009.185348

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  53 in total

Review 1.  Bronchiectasis: new findings in the pathogenesis and treatment of this disease.

Authors:  Jonathan Ilowite; Peter Spiegler; Shalinee Chawla
Journal:  Curr Opin Infect Dis       Date:  2008-04       Impact factor: 4.915

Review 2.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

Review 3.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

4.  Slow breathing reduces sympathoexcitation in COPD.

Authors:  T Raupach; F Bahr; P Herrmann; L Luethje; K Heusser; G Hasenfuss; L Bernardi; S Andreas
Journal:  Eur Respir J       Date:  2008-04-02       Impact factor: 16.671

5.  Firing properties of sudomotor neurones in hyperhidrosis and thermal sweating.

Authors:  Vaughan G Macefield; Yrsa B Sverrisdottir; Mikael Elam; John Harris
Journal:  Clin Auton Res       Date:  2008-11-06       Impact factor: 4.435

Review 6.  Bronchiectasis in adults: a review.

Authors:  Angeline Lazarus; Janet Myers; Gregory Fuhrer
Journal:  Postgrad Med       Date:  2008-09       Impact factor: 3.840

7.  Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

Authors:  D M Mannino; D Thorn; A Swensen; F Holguin
Journal:  Eur Respir J       Date:  2008-06-25       Impact factor: 16.671

Review 8.  The overlap syndrome: chronic obstructive pulmonary disease and obstructive sleep apnea.

Authors:  David Hiestand; Barbara Phillips
Journal:  Crit Care Clin       Date:  2008-07       Impact factor: 3.598

9.  Alveolar-derived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome.

Authors:  Antonio Foresi; Clementina Leone; Dario Olivieri; George Cremona
Journal:  Chest       Date:  2007-07-23       Impact factor: 9.410

Review 10.  Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.

Authors:  Carlos Zamarrón; Vanesa García Paz; Emilio Morete; Felix del Campo Matías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more
  16 in total

Review 1.  Quantifying needles in a haystack: the firing properties of single sympathetic vasoconstrictor neurones in chronic obstructive pulmonary disease.

Authors:  Craig D Steinback
Journal:  J Physiol       Date:  2010-09-01       Impact factor: 5.182

2.  Sympathetic neural activation: an ordered affair.

Authors:  Craig D Steinback; Aryan Salmanpour; Toni Breskovic; Zeljko Dujic; J Kevin Shoemaker
Journal:  J Physiol       Date:  2010-10-11       Impact factor: 5.182

3.  Sympathetic overdrive in obesity involves purinergic hyperactivity in the resistance vasculature.

Authors:  Rebecca E Haddock; Caryl E Hill
Journal:  J Physiol       Date:  2011-05-16       Impact factor: 5.182

4.  Activity of muscle sympathetic neurons during normotensive pregnancy.

Authors:  Sydney M L Schmidt; Charlotte W Usselman; Eric Martinek; Michael K Stickland; Colleen G Julian; Radha Chari; Rshmi Khurana; Sandra T Davidge; Margie H Davenport; Craig D Steinback
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-10-18       Impact factor: 3.619

Review 5.  Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization.

Authors:  Emma C Hart; Geoffrey A Head; Jason R Carter; B Gunnar Wallin; Clive N May; Shereen M Hamza; John E Hall; Nisha Charkoudian; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-31       Impact factor: 4.733

6.  Respiratory modulation of muscle sympathetic nerve activity is not increased in essential hypertension or chronic obstructive pulmonary disease.

Authors:  Rania Fatouleh; Vaughan G Macefield
Journal:  J Physiol       Date:  2011-08-15       Impact factor: 5.182

7.  Baroreceptor sensitivity after Valsalva maneuver in women with chronic obstructive pulmonary disease.

Authors:  Matthew N Bartels; G J Gates; J A Downey; H F Armstrong; R E De Meersman
Journal:  Clin Auton Res       Date:  2012-04-11       Impact factor: 4.435

Review 8.  Current Approaches to Quantifying Tonic and Reflex Autonomic Outflows Controlling Cardiovascular Function in Humans and Experimental Animals.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

9.  Effect of varying chemoreflex stress on sympathetic neural recruitment strategies during apnea.

Authors:  Elizabeth P Ott; Sarah E Baker; Walter W Holbein; J Kevin Shoemaker; Jacqueline K Limberg
Journal:  J Neurophysiol       Date:  2019-08-07       Impact factor: 2.714

Review 10.  β-blockade: benefits beyond blood pressure reduction?

Authors:  John R Cockcroft; Michala E Pedersen
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-11-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.